bpc-157 risks humans is being marketed as a “healing peptide” for tendon injuries, joint pain, gut repair, inflammation, and recovery. The problem is that “healing” biology is not always simple in people with cancer What is BPC-157? | Everything

Our peptides are manufactured in ISO-certified facilities under strict quality control protocols, ensuring consistency from batch to batch

However, we can usually manage it with ease when patients are consistent with their prevention using medications and skincare at home

If these develop, ultrasound evaluation is necessary

F.et al (2019)

Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing